For laboratory research use only. Not for human consumption. All compounds referenced in this article are sold by Explicit SARMs solely as reference materials for in-vitro and animal research by qualified professionals. Nothing here is medical advice, and no statement has been evaluated by the FDA. These materials are not intended to diagnose, treat, cure or prevent any disease.
Tesamorelin is the most extensively characterized of the modified GHRH analogs. This FAQ covers what it is, how it compares with related compounds and what to check when sourcing it. Explicit SARMs supplies tesamorelin in 2mg, 5mg, 10mg and 20mg vials, plus a Tesamorelin/Ipamorelin blend, strictly as laboratory reference material.
About the Compound
What is tesamorelin?
Tesamorelin is a synthetic analog of the full 44-amino-acid growth hormone–releasing hormone, GHRH(1-44), with a trans-3-hexenoyl group added at the N-terminus. The modification is designed to improve resistance to enzymatic breakdown. It acts on the GHRH receptor.
How does it differ from sermorelin and CJC-1295?
Sermorelin is the unmodified 1-29 fragment of GHRH. CJC-1295 is a modified 1-29 analog designed for a longer duration of action. Tesamorelin is based on the full-length sequence.
Is tesamorelin a GHRP?
No. GHRPs such as ipamorelin act on the ghrelin receptor. Tesamorelin is a GHRH analog.
Sourcing Questions
Is your tesamorelin a pharmaceutical product?
No. A pharmaceutical formulation is approved in the US for a specific clinical indication. The material we supply is a research reference material, is not that product, and is sold for research only.
How is it tested?
Our tesamorelin comes from US domestic manufacturing with two tests by our manufacturer, plus purity testing by an independent third-party lab. A COA is available on request through our contact page.
Does it appear on anti-doping lists?
Yes. GHRH and its analogs appear on the World Anti-Doping Agency’s prohibited list.
Do you provide dosing or usage guidance?
No. Tesamorelin is sold strictly for laboratory research, and we do not provide dosing, administration or usage guidance.